MARAMPON, Francesco
MARAMPON, Francesco
Dipartimento di Medicina clinica, sanità pubblica, scienze della vita e dell'ambiente
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results
2016-01-01 DE FELICE, Francesca; Musio, Daniela; Gravina, GIOVANNI LUCA; Marampon, Francesco; Tombolini, Vincenzo
Allosteric modulators of g protein-coupled dopamine and serotonin receptors: A new class of atypical antipsychotics
2020-01-01 Fasciani, I.; Petragnano, F.; Aloisi, G.; Marampon, F.; Carli, M.; Scarselli, M.; Maggio, R.; Rossi, M.
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo
2020-01-01 Colapietro, A.; Gravina, G. L.; Petragnano, F.; Fasciani, I.; Scicchitano, B. M.; Beirinckx, F.; Pujuguet, P.; Saniere, L.; Van Der Aar, E.; Musio, D.; De Felice, F.; Mattei, V.; Martellucci, S.; Maggio, R.; Tombolini, V.; Festuccia, C.; Marampon, F.
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis
2019-01-01 Ferella, L.; Limoncin, E.; Vittorini, F.; Chalaszczyk, A.; Sorce, C.; Grimaldi, G.; Franzese, P.; Ruggieri, V.; Varrassi, E.; Di Staso, M.; Gimenez De Lorenzo, R.; Marampon, F.; Tombolini, V.; Masciocchi, C.; Gravina, G. L.
ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma
2022-01-01 Gravina, G. L.; Colapietro, A.; Mancini, A.; Rossetti, A.; Martellucci, S.; Ventura, L.; Di Franco, M.; Marampon, F.; Mattei, V.; Biordi, L. A.; Otterlei, M.; Festuccia, C.
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma
2022-01-01 Colapietro, A.; Yang, P.; Rossetti, A.; Mancini, A.; Vitale, F.; Chakraborty, S.; Martelluci, S.; Marampon, F.; Mattei, V.; Gravina, G. L.; Iorio, R.; Newman, R. A.; Festuccia, C.
The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models
2019-01-01 Gravina, Giovanni Luca; Mancini, Andrea; Colapietro, Alessandro; Delle Monache, Simona; Sferra, Roberta; Pompili, Simona; Vitale, Flora; Martellucci, Stefano; Marampon, Francesco; Mattei, Vincenzo; Biordi, Leda; Sherris, David; Festuccia, Claudio
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma
2017-01-01 Gravina, GIOVANNI LUCA; Mancini, Andrea; Marampon, Francesco; Colapietro, Alessandro; DELLE MONACHE, Simona; Sferra, Roberta; Vitale, Flora; Richardson, Peter J.; Patient, Lee; Burbidge, Stephen; Festuccia, Claudio
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization
2020-01-01 Petragnano, F.; Pietrantoni, I.; Camero, S.; Codenotti, S.; Milazzo, L.; Vulcano, F.; Macioce, G.; Giordani, I.; Tini, P.; Cheleschi, S.; Gravina, G. L.; Festuccia, C.; Rossetti, A.; Delle Monache, S.; Ordinelli, A.; Ciccarelli, C.; Mauro, A.; Barbara, B.; Antinozzi, C.; Schiavetti, A.; Maggio, R.; Di Luigi, L.; Polimeni, A.; Marchese, C.; Tombolini, V.; Fanzani, A.; Bernabo, N.; Megiorni, F.; Marampon, F.
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8)
2019-01-01 Marampon, F.; Leoni, F.; Mancini, A.; Pietrantoni, I.; Codenotti, S.; Ferella, L.; Megiorni, F.; Porro, G.; Galbiati, E.; Pozzi, P.; Mascagni, P.; Budillon, A.; Maggio, R.; Tombolini, V.; Fanzani, A.; Gravina, G. L.; Festuccia, C.
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6)
2018-01-01 Festuccia, C; Mancini, A; Colapietro, A; Gravina, G L; Vitale, F; Marampon, F; Delle Monache, S; Pompili, S; Cristiano, L; Vetuschi, A; Tombolini, V; Chen, Y; Mehrling, T
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage
2016-01-01 Marampon, Francesco; Gravina, GIOVANNI LUCA; Ju, X; Vetuschi, Antonella; Sferra, Roberta; Casimiro, M. C; Pompili, Simona; Festuccia, Claudio; Colapietro, Alessandro; Gaudio, E; DI CESARE, Ernesto; Tombolini, V; Pestell, R. G.
Dichlorodiphenyltrichloroethane, an old pesticide with a new mechanism of toxicity
2018-01-01 Pietrantoni, Ilaria; Rossi, Mario; Scarselli, Marco; Fasciani, Irene; Marampon, Francesco; Maggio, Roberto
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo
2018-01-01 Ciccarelli, C.; Di Rocco, A.; Gravina, G. L.; Mauro, A.; Festuccia, C.; Del Fattore, A.; Berardinelli, P.; De Felice, F.; Musio, D.; Bouche, M.; Tombolini, V.; Zani, B. M.; Marampon, F.
Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3receptors
2018-01-01 Fasciani, Irene; Pietrantoni, Ilaria; Rossi, Mario; Mannoury la Cour, Clotilde; Aloisi, Gabriella; Marampon, Francesco; Scarselli, Marco; Millan, Mark J; Maggio, Roberto
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models
2016-01-01 Gravina, GIOVANNI LUCA; Mancini, Andrea; Scarsella, Luca; Colapietro, Alessandro; Jitariuc, Ana; Vitale, Flora; Marampon, Francesco; Ricevuto, Enrico; Festuccia, Claudio
The First Negative Allosteric Modulator for Dopamine D2and D3Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs
2017-01-01 Rossi, Mario; Fasciani, Irene; Marampon, Francesco; Maggio, Roberto; Scarselli, Marco
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma
2018-01-01 Festuccia, Claudio; Mancini, Andrea; Colapietro, Alessandro; Gravina, Giovanni Luca; Vitale, Flora; Marampon, Francesco; Delle Monache, Simona; Pompili, Simona; Cristiano, Loredana; Vetuschi, Antonella; Tombolini, Vincenzo; Chen, Yi; Mehrling, Thomas
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma
2018-01-01 Marampon, Francesco; Leoni, Flavio; Mancini, Andrea; Pietrantoni, Ilaria; Codenotti, Silvia; Ferella, Letizia; Megiorni, Francesca; Porro, Giuliana; Galbiati, Elisabetta; Pozzi, Pietro; Mascagni, Paolo; Budillon, Alfredo; Maggio, Roberto; Tombolini, Vincenzo; Fanzani, Alessandro; Gravina, Giovanni Luca; Festuccia, Claudio
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and surviving in prostate cancer models
2015-01-01 Gravina, GIOVANNI LUCA; Mancini, Andrea; Sanita', Patrizia; Vitale, Flora; Marampon, Francesco; Ventura, Luca; Landesman, Yosef; Mccauley, Dilara; Kauffman, Michael; Shacham, Sharon; Festuccia, Claudio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results | 1-gen-2016 | DE FELICE, Francesca; Musio, Daniela; Gravina, GIOVANNI LUCA; Marampon, Francesco; Tombolini, Vincenzo | |
| Allosteric modulators of g protein-coupled dopamine and serotonin receptors: A new class of atypical antipsychotics | 1-gen-2020 | Fasciani, I.; Petragnano, F.; Aloisi, G.; Marampon, F.; Carli, M.; Scarselli, M.; Maggio, R.; Rossi, M. | |
| Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo | 1-gen-2020 | Colapietro, A.; Gravina, G. L.; Petragnano, F.; Fasciani, I.; Scicchitano, B. M.; Beirinckx, F.; Pujuguet, P.; Saniere, L.; Van Der Aar, E.; Musio, D.; De Felice, F.; Mattei, V.; Martellucci, S.; Maggio, R.; Tombolini, V.; Festuccia, C.; Marampon, F. | |
| Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis | 1-gen-2019 | Ferella, L.; Limoncin, E.; Vittorini, F.; Chalaszczyk, A.; Sorce, C.; Grimaldi, G.; Franzese, P.; Ruggieri, V.; Varrassi, E.; Di Staso, M.; Gimenez De Lorenzo, R.; Marampon, F.; Tombolini, V.; Masciocchi, C.; Gravina, G. L. | |
| ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma | 1-gen-2022 | Gravina, G. L.; Colapietro, A.; Mancini, A.; Rossetti, A.; Martellucci, S.; Ventura, L.; Di Franco, M.; Marampon, F.; Mattei, V.; Biordi, L. A.; Otterlei, M.; Festuccia, C. | |
| The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma | 1-gen-2022 | Colapietro, A.; Yang, P.; Rossetti, A.; Mancini, A.; Vitale, F.; Chakraborty, S.; Martelluci, S.; Marampon, F.; Mattei, V.; Gravina, G. L.; Iorio, R.; Newman, R. A.; Festuccia, C. | |
| The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models | 1-gen-2019 | Gravina, Giovanni Luca; Mancini, Andrea; Colapietro, Alessandro; Delle Monache, Simona; Sferra, Roberta; Pompili, Simona; Vitale, Flora; Martellucci, Stefano; Marampon, Francesco; Mattei, Vincenzo; Biordi, Leda; Sherris, David; Festuccia, Claudio | |
| The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma | 1-gen-2017 | Gravina, GIOVANNI LUCA; Mancini, Andrea; Marampon, Francesco; Colapietro, Alessandro; DELLE MONACHE, Simona; Sferra, Roberta; Vitale, Flora; Richardson, Peter J.; Patient, Lee; Burbidge, Stephen; Festuccia, Claudio | |
| Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization | 1-gen-2020 | Petragnano, F.; Pietrantoni, I.; Camero, S.; Codenotti, S.; Milazzo, L.; Vulcano, F.; Macioce, G.; Giordani, I.; Tini, P.; Cheleschi, S.; Gravina, G. L.; Festuccia, C.; Rossetti, A.; Delle Monache, S.; Ordinelli, A.; Ciccarelli, C.; Mauro, A.; Barbara, B.; Antinozzi, C.; Schiavetti, A.; Maggio, R.; Di Luigi, L.; Polimeni, A.; Marchese, C.; Tombolini, V.; Fanzani, A.; Bernabo, N.; Megiorni, F.; Marampon, F. | |
| Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) | 1-gen-2019 | Marampon, F.; Leoni, F.; Mancini, A.; Pietrantoni, I.; Codenotti, S.; Ferella, L.; Megiorni, F.; Porro, G.; Galbiati, E.; Pozzi, P.; Mascagni, P.; Budillon, A.; Maggio, R.; Tombolini, V.; Fanzani, A.; Gravina, G. L.; Festuccia, C. | |
| Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) | 1-gen-2018 | Festuccia, C; Mancini, A; Colapietro, A; Gravina, G L; Vitale, F; Marampon, F; Delle Monache, S; Pompili, S; Cristiano, L; Vetuschi, A; Tombolini, V; Chen, Y; Mehrling, T | |
| Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage | 1-gen-2016 | Marampon, Francesco; Gravina, GIOVANNI LUCA; Ju, X; Vetuschi, Antonella; Sferra, Roberta; Casimiro, M. C; Pompili, Simona; Festuccia, Claudio; Colapietro, Alessandro; Gaudio, E; DI CESARE, Ernesto; Tombolini, V; Pestell, R. G. | |
| Dichlorodiphenyltrichloroethane, an old pesticide with a new mechanism of toxicity | 1-gen-2018 | Pietrantoni, Ilaria; Rossi, Mario; Scarselli, Marco; Fasciani, Irene; Marampon, Francesco; Maggio, Roberto | |
| Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo | 1-gen-2018 | Ciccarelli, C.; Di Rocco, A.; Gravina, G. L.; Mauro, A.; Festuccia, C.; Del Fattore, A.; Berardinelli, P.; De Felice, F.; Musio, D.; Bouche, M.; Tombolini, V.; Zani, B. M.; Marampon, F. | |
| Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3receptors | 1-gen-2018 | Fasciani, Irene; Pietrantoni, Ilaria; Rossi, Mario; Mannoury la Cour, Clotilde; Aloisi, Gabriella; Marampon, Francesco; Scarselli, Marco; Millan, Mark J; Maggio, Roberto | |
| Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models | 1-gen-2016 | Gravina, GIOVANNI LUCA; Mancini, Andrea; Scarsella, Luca; Colapietro, Alessandro; Jitariuc, Ana; Vitale, Flora; Marampon, Francesco; Ricevuto, Enrico; Festuccia, Claudio | |
| The First Negative Allosteric Modulator for Dopamine D2and D3Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs | 1-gen-2017 | Rossi, Mario; Fasciani, Irene; Marampon, Francesco; Maggio, Roberto; Scarselli, Marco | |
| The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma | 1-gen-2018 | Festuccia, Claudio; Mancini, Andrea; Colapietro, Alessandro; Gravina, Giovanni Luca; Vitale, Flora; Marampon, Francesco; Delle Monache, Simona; Pompili, Simona; Cristiano, Loredana; Vetuschi, Antonella; Tombolini, Vincenzo; Chen, Yi; Mehrling, Thomas | |
| Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma | 1-gen-2018 | Marampon, Francesco; Leoni, Flavio; Mancini, Andrea; Pietrantoni, Ilaria; Codenotti, Silvia; Ferella, Letizia; Megiorni, Francesca; Porro, Giuliana; Galbiati, Elisabetta; Pozzi, Pietro; Mascagni, Paolo; Budillon, Alfredo; Maggio, Roberto; Tombolini, Vincenzo; Fanzani, Alessandro; Gravina, Giovanni Luca; Festuccia, Claudio | |
| KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and surviving in prostate cancer models | 1-gen-2015 | Gravina, GIOVANNI LUCA; Mancini, Andrea; Sanita', Patrizia; Vitale, Flora; Marampon, Francesco; Ventura, Luca; Landesman, Yosef; Mccauley, Dilara; Kauffman, Michael; Shacham, Sharon; Festuccia, Claudio |